it is concluded that the greater demonstrable efficacy of treatment with photofrin ii , as compared to treatment with photofrin , is due to enrichment of those nonpolar hydrophobic components of the hematoporphyrin derivative mixture that are thought to be primarily responsible for the in vivo biologic activities .
C0729236
photofrin
C0121300
hematoporphyrin derivative